Molecular Pathophysiology and Treatment of Coronary Artery Disease
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 20 November 2025 | Viewed by 235
Special Issue Editor
Interests: cardiovascular system; cardiac sarcoidosis; coronary artery disease; vein anastomosis; dilated cardiomyopathy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Coronary artery disease (CAD) is a complex and heterogeneous condition. Etiologically based therapy is the best option. The molecular pathophysiology of CAD involves a combination of inflammatory processes, and lipid accumulation, which can lead to the progression of atherosclerosis, myocardial ischemia, and adverse cardiovascular events, including heart failure and sudden cardiac death. Despite significant advancements in understanding these mechanisms, the relative roles of genetic predisposition, environmental factors, and inflammatory pathways in disease initiation and progression remain subjects of ongoing debate.
This Special Issue is dedicated to the molecular pathophysiology and treatment of coronary artery-related diseases, including immune-related adverse events, coronary artery-related cardiovascular diseases. Research articles and reviews will inform you about recent developments and update the current stage of knowledge.
Dr. Kazufumi Nakamura
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- coronary artery disease
- ischemic cardiomyopathy
- immune-related adverse events
- CAD associated with autoimmune diseases
- coronary artery disease-related cardiomyopathy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
